Last Posted: Jul 24, 2020
- MSH6 immunohistochemical heterogeneity in colorectal cancer: comparative sequencing from different tumor areas.
Chen Wei et al. Human pathology 2020 96104-111 - Clinical and Molecular Assessment of Patients with Lynch Syndrome and Sarcomas Underpinning the Association with MSH2 Germline Pathogenic Variants.
de Angelis de Carvalho Nathália et al. Cancers 2020 Jul 12(7) - Comparisons of screening strategies for identifying Lynch syndrome among patients with MLH1-deficient colorectal cancer.
Xiao Binyi et al. European journal of human genetics : EJHG 2020 Jul - Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer-A Systematic Review.
Sroczynski Gaby et al. Cancers 2020 Jul 12(7) - Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, 4th Edition.
Ebi Hiromichi et al. Cancer science 2020 Jul - A snapshot of current genetic testing practice in Lynch syndrome: The results of a representative survey of 33 Latin American existing centres/registries.
Della Valle Adriana et al. European journal of cancer (Oxford, England : 1990) 2019 119112-121 - Clinical outcomes of a genomic screening program for actionable genetic conditions.
Buchanan Adam H et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Jun - Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer?
Marabelli Monica et al. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2020 Jun - Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals.
Lacaze Paul et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Jul - Strategies to Identify and Care for Individuals with Inherited Cancer Syndromes
NCI Webinar, July 30, 2020
.png)
No hay comentarios:
Publicar un comentario